Growing community of inventors

Columbia, MD, United States of America

Qi Su

Average Co-Inventor Count = 4.69

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Qi SuHao Chen (5 patents)Qi SuMing Liu (5 patents)Qi SuLisa Leary (3 patents)Qi SuManish Raisinghani (2 patents)Qi SuMalathi Sathyamoorthy (1 patent)Qi SuAlexel Miagkov (1 patent)Qi SuAlexei Miagkov (1 patent)Qi SuWayne Shaobin Zhong (1 patent)Qi SuQi Su (5 patents)Hao ChenHao Chen (10 patents)Ming LiuMing Liu (5 patents)Lisa LearyLisa Leary (3 patents)Manish RaisinghaniManish Raisinghani (2 patents)Malathi SathyamoorthyMalathi Sathyamoorthy (3 patents)Alexel MiagkovAlexel Miagkov (1 patent)Alexei MiagkovAlexei Miagkov (1 patent)Wayne Shaobin ZhongWayne Shaobin Zhong (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Caliper Life Sciences, Inc. (4 from 149 patents)

2. Other (1 from 832,912 patents)

3. The Perkin-Elmer Corporation (801 patents)


5 patents:

1. 9604945 - Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders

2. 9149466 - Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions

3. 9119843 - Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions

4. 8691853 - Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions

5. 8415385 - Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…